Your browser doesn't support javascript.
loading
MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan, Jing; Pan, Xiang; Li, Yawen; Hu, Yimin; Tao, Lingzhi; Li, Zuwei; Zhao, Liwen; Wang, Jingyao; Li, Hang; Lai, Yulin; Zhou, Liang; Lin, Canbin; Gui, Yaoting; Ye, Jing; Zhang, Fangting; Lai, Yongqing.
Affiliation
  • Quan J; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Anhui Medical University, Hefei, Anhui, 230032, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital,
  • Pan X; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Anhui Medical University, Hefei, Anhui, 230032, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital,
  • Li Y; Anhui Medical University, Hefei, Anhui, 230032, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China. Electronic address: liya
  • Hu Y; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 846523886@qq.com.
  • Tao L; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 3588023632@qq.com.
  • Li Z; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 13592854057@163.com.
  • Zhao L; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Anhui Medical University, Hefei, Anhui, 230032, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital,
  • Wang J; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 5180
  • Li H; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 413089962@qq.com.
  • Lai Y; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 13613611@qq.com.
  • Zhou L; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 763050941@qq.com.
  • Lin C; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 5180
  • Gui Y; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 18565797816@163.com.
  • Ye J; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 1258382592@qq.com.
  • Zhang F; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 518036, P.R. China. Electronic address: 1722403360@qq.com.
  • Lai Y; Department of Urology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, P.R. China; Guangdong and Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, Institute of Urology, Peking University Shenzhen Hospital, Shenzhen PKU-HKUST Medical Center, Shenzhen, Guangdong 5180
Biomed Pharmacother ; 110: 656-666, 2019 Feb.
Article in En | MEDLINE | ID: mdl-30551118
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Oncogenes / Carcinoma, Renal Cell / Biomarkers, Tumor / Trans-Activators / Receptors, Cytoplasmic and Nuclear / MicroRNAs / Kidney Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biomed Pharmacother Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Oncogenes / Carcinoma, Renal Cell / Biomarkers, Tumor / Trans-Activators / Receptors, Cytoplasmic and Nuclear / MicroRNAs / Kidney Neoplasms Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Biomed Pharmacother Year: 2019 Document type: Article